Lung Immune Defenses

The respiratory tract maintains a balanced immune system that protects a large mucosal surface from inhaled pathogens while avoiding excessive inflammation that would impair gas exchange. Innate barriers and cells act immediately, adaptive immunity provides specificity and memory, and regulatory mechanisms keep responses proportionate at the air-tissue interface.

Definition

Lung immune defenses are the innate and adaptive immunological mechanisms of the respiratory tract that recognise and eliminate inhaled pathogens at the airway and alveolar mucosa while regulating the response to preserve gas-exchange function.

Scope

This topic covers the layered immune defences of the lung: physical and secreted innate barriers, resident and recruited immune cells (notably alveolar macrophages), the contribution of surfactant collectins, and adaptive mucosal immunity, together with the regulation that maintains tolerance to harmless inhaled material. It is reference-educational physiology, not clinical immunology guidance.

Core questions

• What innate barriers and cells provide the lung's first response to inhaled microbes?
• How do alveolar macrophages clear pathogens without provoking damaging inflammation?
• How does adaptive mucosal immunity add specificity and memory in the respiratory tract?
• How is immune homeostasis maintained so the lung tolerates harmless inhaled material?

Key concepts

• Innate versus adaptive respiratory immunity
• Alveolar macrophages
• Mucosal immunity and secretory IgA
• Pattern recognition and surfactant collectins (SP-A, SP-D)
• Antimicrobial peptides
• Immune homeostasis and tolerance

Mechanisms

Defence begins with innate barriers: the epithelial lining, mucociliary clearance and secreted antimicrobial molecules, supported by surfactant collectins SP-A and SP-D that opsonise microbes and modulate immune cells. Alveolar macrophages patrol the alveolar surface, phagocytose and degrade inhaled particles and pathogens, and help set the inflammatory tone. When innate defences are insufficient, dendritic cells sample antigen and prime adaptive responses, generating antigen-specific T cells and antibodies, including secretory immunoglobulin at the mucosa, that confer specificity and memory. Throughout, regulatory networks restrain responses to harmless inhaled antigens, maintaining immunological homeostasis so that protection does not come at the cost of inflammatory injury to the gas-exchange surface.

Clinical relevance

Understanding lung immune defences clarifies why breaches of barriers, impaired phagocytosis or dysregulated inflammation predispose to respiratory infection and immune-mediated lung injury. The topic is descriptive physiology framing such processes and does not provide diagnostic or treatment recommendations.

Evidence & guidelines

Respiratory immune function is described in immunology reviews and respiratory medicine textbooks; management of specific infections or immune disorders sits with the relevant clinical entities and guidelines.

History

The lung was progressively recognised as an immunologically active mucosal organ over the late twentieth and early twenty-first centuries, as the roles of alveolar macrophages, surfactant collectins and mucosal adaptive immunity were defined and integrated into a model of regulated respiratory host defence.

Key figures

• Patrick Holt
• Jo Rae Wright
• Erika Crouch

Seminal works

• holt-2008
• wright-2005
• crouch-2001

Frequently asked questions

How does the lung defend itself against inhaled microbes?

Through layered defences: physical and secreted innate barriers, surfactant proteins that recognise microbes, alveolar macrophages that engulf them, and adaptive mucosal immunity that adds specific antibodies and memory.

Why does the lung need to regulate its immune responses?

Because uncontrolled inflammation would damage the thin gas-exchange surface, the respiratory immune system is regulated to tolerate harmless inhaled material while still responding to genuine threats.